Inventor · disambiguated record
Stephen E. Zale
Also filed as: ZALE STEPHEN · ZALE STEPHEN E
53 granted patents·34 pending applications·4,209 citations·filing 1992–2024
99Inventor score
Top patents by PatentIndex Score
87 records- 0199US8603499B2Cancer cell targeting using nanoparticlesBIND THERAPEUTICS INC·Filed 2013·Granted Dec 10, 2013·112 cites·4 claims
- 0299US8603501B2Cancer cell targeting using nanoparticlesBIND THERAPEUTICS INC·Filed 2013·Granted Dec 10, 2013·113 cites·12 claims
- 0399US8603500B2Cancer cell targeting using nanoparticlesBIND THERAPEUTICS INC·Filed 2013·Granted Dec 10, 2013·111 cites·10 claims
- 0499US8273363B2Cancer cell targeting using nanoparticlesZALE STEPHEN E·Filed 2011·Granted Sep 25, 2012·82 cites·4 claims
- 0599US8246968B2Cancer cell targeting using nanoparticlesZALE STEPHEN E·Filed 2008·Granted Aug 21, 2012·193 cites·4 claims
- 0699US8236330B2Cancer cell targeting using nanoparticlesZALE STEPHEN E·Filed 2011·Granted Aug 7, 2012·146 cites·11 claims
- 0798US8709483B2System for targeted delivery of therapeutic agentsFAROKHZAD OMID C·Filed 2008·Granted Apr 29, 2014·129 cites·43 claims
- 0898US8637083B2Stable formulations for lyophilizing therapeutic particlesBIND THERAPEUTICS INC·Filed 2013·Granted Jan 28, 2014·82 cites·19 claims
- 0998US8617608B2Drug loaded polymeric nanoparticles and methods of making and using sameBIND THERAPEUTICS INC·Filed 2013·Granted Dec 31, 2013·119 cites·28 claims
- 1098US8613954B2Drug loaded polymeric nanoparticles and methods of making and using sameBIND THERAPEUTICS INC·Filed 2013·Granted Dec 24, 2013·114 cites·30 claims
- 1198US8613951B2Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using sameZALE STEPHEN E·Filed 2009·Granted Dec 24, 2013·147 cites·24 claims
- 1298US8603534B2Drug loaded polymeric nanoparticles and methods of making and using sameBIND THERAPEUTICS INC·Filed 2013·Granted Dec 10, 2013·97 cites·13 claims
- 1398US8603535B2Stable formulations for lyophilizing therapeutic particlesBIND THERAPEUTICS INC·Filed 2013·Granted Dec 10, 2013·85 cites·11 claims
- 1498US8318211B2Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using sameZALE STEPHEN E·Filed 2009·Granted Nov 27, 2012·149 cites·15 claims
- 1598US8318208B1Drug loaded polymeric nanoparticles and methods of making and using sameZALE STEPHEN E·Filed 2012·Granted Nov 27, 2012·145 cites·24 claims
- 1698US8211473B2Stable formulations for lyophilizing therapeutic particlesTROIANO GREG·Filed 2011·Granted Jul 3, 2012·117 cites·13 claims
- 1798US8206747B2Drug loaded polymeric nanoparticles and methods of making and using sameZALE STEPHEN E·Filed 2009·Granted Jun 26, 2012·182 cites·17 claims
- 1898US6667061B2Preparation of injectable suspensions having improved injectabilityALKERMES INC·Filed 2002·Granted Dec 23, 2003·89 cites·23 claims
- 1998US6495164B1Preparation of injectable suspensions having improved injectabilityALKERMES INC·Filed 2000·Granted Dec 17, 2002·246 cites·53 claims
- 2098US5916597AComposition and method using solid-phase particles for sustained in vivo release of a biologically active agentALKERMES INC·Filed 1996·Granted Jun 29, 1999·601 cites·18 claims
- 2197US9295727B2Cancer cell targeting using nanoparticlesBIND THERAPEUTICS INC·Filed 2014·Granted Mar 29, 2016·33 cites·4 claims
- 2297US8623417B1Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using sameBIND THERAPEUTICS INC·Filed 2013·Granted Jan 7, 2014·29 cites·16 claims
- 2396US8802153B2System for targeted delivery of therapeutic agentsMASSACHUSETTS INST TECHNOLOGY·Filed 2013·Granted Aug 12, 2014·37 cites·16 claims
- 2496US8734846B2Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticlesBIND BIOSCIENCES INC·Filed 2012·Granted May 27, 2014·135 cites·20 claims
- 2596US8357401B2Stable formulations for lyophilizing therapeutic particlesBIND BIOSCIENCES INC·Filed 2010·Granted Jan 22, 2013·30 cites·16 claims
- 2696US5716644AComposition for sustained release of non-aggregated erythropoietinALKERMES INC·Filed 1995·Granted Feb 10, 1998·244 cites·4 claims
- 2796US5674534AComposition for sustained release of non-aggregated erythropoietinALKERMES INC·Filed 1995·Granted Oct 7, 1997·238 cites·29 claims
- 2893US8563041B2Therapeutic particles suitable for parenteral administration and methods of making and using sameGRAYSON AMY·Filed 2009·Granted Oct 22, 2013·91 cites·4 claims
- 2993US7371406B2Preparation of injectable suspensions having improved injectabilityALKERMES INC·Filed 2003·Granted May 13, 2008·32 cites·20 claims
- 3093US5683916AMembrane affinity apparatus and purification methods related theretoHEMASURE INC·Filed 1995·Granted Nov 4, 1997·126 cites·30 claims
- 3192US7799345B2Preparation of injectable suspensions having improved injectabilityALKERMES INC·Filed 2007·Granted Sep 21, 2010·6 cites·12 claims
- 3287US8912212B2Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymersBIND THERAPEUTICS INC·Filed 2013·Granted Dec 16, 2014·7 cites·11 claims
- 3386US9393310B2Drug loaded polymeric nanoparticles and methods of making and using sameZALE STEPHEN E·Filed 2012·Granted Jul 19, 2016·4 cites·20 claims
- 3484US12023406B2Gastric residence systems with release rate-modulating filmsLYNDRA THERAPEUTICS INC·Filed 2018·Granted Jul 2, 2024·2 cites·57 claims
- 3584US10071056B2Cancer cell targeting using nanoparticlesPFIZER·Filed 2016·Granted Sep 11, 2018·2 cites·6 claims
- 3683US9872848B2Stable formulations for lyophilizing therapeutic particlesPFIZER·Filed 2016·Granted Jan 23, 2018·2 cites·17 claims
- 3782US12109305B2Materials architecture for gastric residence systemsLYNDRA THERAPEUTICS INC·Filed 2017·Granted Oct 8, 2024·3 cites·34 claims
- 3882US11576866B2Gastric residence systems for sustained delivery of adamantane-class drugsLYNDRA THERAPEUTICS INC·Filed 2017·Granted Feb 14, 2023·5 cites·22 claims
- 3982US9579386B2Drug loaded polymeric nanoparticles and methods of making and using samePFIZER·Filed 2012·Granted Feb 28, 2017·2 cites·24 claims
- 4082US9198874B2Long circulating nanoparticles for sustained release of therapeutic agentsBIND THERAPEUTICS INC·Filed 2013·Granted Dec 1, 2015·3 cites·11 claims
- 4181US5362859AHigh-capacity affinity supports and methods for the preparation and use of sameSEPRACOR INC·Filed 1992·Granted Nov 8, 1994·44 cites·20 claims
- 4280US8956657B2Stable formulations for lyophilizing therapeutic particlesBIND THERAPEUTICS INC·Filed 2013·Granted Feb 17, 2015·2 cites·24 claims
- 4380US5310688AMethod and apparatus for eluting proteins in affinity membrane processSEPRACOR INC·Filed 1993·Granted May 10, 1994·48 cites·4 claims
- 4478US10137088B2Therapeutic nanoparticles having EGFR ligands and methods of making and using samePFIZER·Filed 2016·Granted Nov 27, 2018·2 cites·9 claims
- 4576US8905997B2Therapeutic particles suitable for parenteral administration and methods of making and using sameBIND THERAPEUTICS INC·Filed 2013·Granted Dec 9, 2014·1 cites·13 claims
- 4676US2024423909A1Materials architecture for gastric residence systemsLYNDRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4775US8916203B2Stable formulations for lyophilizing therapeutic particlesBIND BIOSCIENCES INC·Filed 2012·Granted Dec 23, 2014·1 cites·14 claims
- 4874US2024382418A1Gastric residence systems with release rate-modulating filmsLYNDRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4973US9308179B2Long circulating nanoparticles for sustained release of therapeutic agentsZALE STEPHEN E·Filed 2012·Granted Apr 12, 2016·1 cites·12 claims
- 5072US9579284B2Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using samePFIZER·Filed 2013·Granted Feb 28, 2017·4 cites·15 claims
Showing the top 50 of 87 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen E. Zale files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →